Medicalsystem Biotechnology (300439.SZ) obtained a medical device registration certificate.
Meikang Biology (300439.SZ) announces that the company has recently obtained a medical device registration certificate issued by the National Medical Products Administration. The product is named: Glucose-6-phosphate dehydrogenase assay kit (glucose-6-phosphate substrate method).
Medicalsystem Biotechnology (300439.SZ) announced that the company recently obtained a medical device registration certificate issued by the National Medical Products Administration. The product is named: Glucose-6-phosphate dehydrogenase assay kit (glucose-6-phosphate substrate method).
Related Articles

Zhixiang Jintai (688443.SH) plans to launch a restricted stock incentive plan in 2026.

Wuchan Zhongda Group plans to repurchase shares worth 200 million to 400 million yuan.

WELLE Environmental Group (300190.SZ) has won the bidding for a sewage treatment project worth 44.88 million yuan.
Zhixiang Jintai (688443.SH) plans to launch a restricted stock incentive plan in 2026.

Wuchan Zhongda Group plans to repurchase shares worth 200 million to 400 million yuan.

WELLE Environmental Group (300190.SZ) has won the bidding for a sewage treatment project worth 44.88 million yuan.

RECOMMEND

Hong Kong Stocks Surge! Buying Opportunity Or Wait And See? Analysts Provide Comprehensive Interpretation
02/04/2026

Narrative Drives Everything As China’s AI Newcomers Enter An Era Of Extreme Volatility, Retail Investors Flood In
02/04/2026

Fund Cohort Stocks Rally As Institutional Confidence In Hong Kong Equities Shows Signs Of Repair
02/04/2026


